SMYD3 and breast carcinoma: Our results confirmed that targeting SMYD3 can inhibit ZNF8‐mediated invasion and metastasis of breast cancer cells, indicating that targeting the mechanism by which ZNF8 recruits SMYD3 may be an effective strategy for the TGF‐β‐mediated lung metastasis of breast cancer.